Cite
MLA Citation
Sophie Glatt et al.. “Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study.” Annals of the rheumatic diseases, vol. 78, no. 8, 2019, pp. 1033–1040. http://access.bl.uk/ark:/81055/vdc_100175518889.0x000063